Caraco Pharmaceutical
Sun Pharma increases holding in Caraco
16 March 2004
Sun Pharma to increase holdings in Caraco to 60 per cent
09 February 2004
Caraco Pharma gets USFDA nod for tizanidine hydrochloride
03 October 2003
Jitendra N Doshi to be interim chief of Caraco Pharmaceuticals
30 August 2003
Caraco, Sun Pharma sign R&D pact for 25 new generic drugs
09 December 2002
Caraco Pharma places $1.6 million privately
16 May 2002
Caraco gets FDA nod for a drug
09 January 2002
 search domain-b